US 6,335,337 B1 · Substituted piperazinones and their therapeutic uses

Abstract

Novel compounds which are inhibitors of the binding of fibrinogen to the Gp iib/iiia platelet receptors, and which can be used therapeutically as antithrombotic agents.

Claims0

Dependent claims

Claims aren’t available for this document.

Facts

Application

09/743,352Filed 9 Jan 2001

Granted

1 Jan 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification7 codes

C07D 241/08
Having one or two double bonds between ring members or between ring members and non-ring members: with oxygen atoms directly attached to ring…
A61P 7/02
Drugs for disorders of the blood or the extracellular fluid: antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
A61P 43/00
Drugs for specific purposes, not provided for in groups a61p1/00-a61p41/00
Y02P 20/55
Improvements relating to the production of bulk chemicals: design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

Novel compounds which are inhibitors of the binding of fibrinogen to the Gp iib/iiia platelet receptors, and which can be used therapeutically as antithrombotic agents.

Substituted piperazinones and their therapeutic uses

Life of this patent

Abstract

Claims0

Substituted piperazinones and their therapeutic uses

Life of this patent

Abstract

Claims0